Investing.com - Bio-Rad Labs (NYSE: BIO) reported second quarter EPS of $3.00, $0.32 better than the analyst estimate of $2.68. Revenue for the quarter came in at $681.1M versus the consensus estimate of $697.96M.
Bio-Rad Labs's stock price closed at $401.80. It is up 4.30% in the last 3 months and down -25.26% in the last 12 months.
Bio-Rad Labs saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Bio-Rad Labs's stock price’s past reactions to earnings here.
According to InvestingPro, Bio-Rad Labs's Financial Health score is "good performance".
Check out Bio-Rad Labs's recent earnings performance, and Bio-Rad Labs's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar